Larvol Delta - Acrivon-Therapeuticsannounced-it-will-be-providing-ACR368-and-ACR2316-clinical-data-and-other-updates-in-January-2026

prexasertib (ACR-368) - Acrivon Therap

ACR-2316 - Acrivon Therap

https://www.manilatimes.net/2025/12/17/tmt-newswire/globenewswire/acrivon-therapeutics-to-announce-clinical-update-on-its-ongoing-phase-2b-studies-and-planned-confirmatory-phase-3-trial-for-acr-368-initial-clinical-data-on-acr-2316-and-other-ap3-pipeline-updates/2245220

Dec 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next